DIN 02407329 — XTANDI 40 MG
XTANDI is a capsule of Enzalutamide marketed by ASTELLAS PHARMA CANADA INC. The full Enzalutamide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02407329
- Brand name
- XTANDI
- Active ingredient
- Enzalutamide
- Strength
- 40 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- ASTELLAS PHARMA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Anti-androgen (androgen receptor inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Enzalutamide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02562677 | APO-ENZALUTAMIDE | 40 MG | CAPSULE | APOTEX INC | MARKETED |
| 02494736 | AURO-ENZALUTAMIDE | 40 MG | CAPSULE | AURO PHARMA INC | MARKETED |
| 02515229 | JAMP ENZALUTAMIDE | 40 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02558424 | REDDY-ENZALUTAMIDE | 40 MG | CAPSULE | DR REDDY'S LABORATORIES LTD | MARKETED |